Table 2.
Main characteristics of patients with and without erectile dysfunction
| No ED (>21 pts) (n = 29) | ED (≤21 pts) (n = 51) | P‐value | |
|---|---|---|---|
| Child‐Pugh score, n (%) | |||
| A: 30 (37.5%) | 14 (48.3%) | 16 (31.4%) | .089 |
| B: 35 (43.75%) | 13 (44.8%) | 22 (43.1%) | |
| C: 15 (18.75%) | 2 (6.9%) | 13 (25.5%) | |
| MELD, mean ± SD | 11.3 ± 3.6 | 13.4 ± 3.9 | .021 |
| Aetiologies, n (%) | |||
| ALD: 38 (47.5%) | 11 (37.9%) | 27 (52.9%) | .491 |
| Viral: 25 (31.3%) | 10 (34.5%) | 15 (29.4%) | |
| Viral/ALD: 7 (8.8%) | 4 (13.8%) | 3 (5.9%) | |
| Others: 10 (12.5%) | 4 (13.8%) | 6 (11.8%) | |
| HVPG, mean ± SDa | 13.6 ± 7.3 | 17.9 ± 5.6 | .028 |
| Previous hepatic decompensation, n (%) | 9 (31%) | 28 (55%) | .040 |
| Presence of oesophageal varices, n (%)b | 15 (57%) | 30 (64%) | .483 |
| HCC baseline, n (%) | |||
| No: 71 (88.8%) | 27 (93.1%) | 44 (86.3%) | .353 |
| Yes: 9 (11.2%) | 2 (6.9%) | 7 (13.7%) | |
| Age, mean ± SD | 49 (±10.4) | 55 (±8) | .006 |
| BMI, mean ± SD | 25.6 (±4) | 27.2 (±4.2) | .091 |
| Art. HTN, n (%) | |||
| No: 54 (67.5%) | 25 (86.2%) | 29 (56.9%) | .007 |
| Yes: 26 (32.5%) | 4 (13.8%) | 22 (43.1%) | |
| Diabetes, n (%) | |||
| No: 55 (68.8%) | 25 (82.8%) | 30 (58.8%) | .011 |
| Yes: 25 (31.2%) | 4 (17.2%) | 21 (41.2%) | |
| Depression, n (%) | |||
| No: 67 (83.8%) | 25 (86.2%) | 42 (82.4%) | .653 |
| Yes: 13 (16.3%) | 4 (13.8%) | 9 (17.6%) | |
| Antidepressive medication, n (%) | |||
| No: 73 (91.3%) | 27 (93.1%) | 46 (90.2%) | .658 |
| Yes: 7 (8.8%) | 2 (6.9%) | 5 (9.8%) | |
| Beta‐blockerc (n = 75), n (%) | |||
| No: 35 (46.7%) | 16 (57.1%) | 19 (40.4%) | .160 |
| Yes: 40 (53.3%) | 12 (42.9%) | 28 (59.6%) | |
| Active Smoker, n (%) | |||
| No: 47 (58.8%) | 13 (44.8%) | 34 (66.7%) | .056 |
| Yes: 33 (41.3%) | 16 (55.2%) | 17 (33.3%) | |
| Libido, n (%) | |||
| Normal | 17 (58.6%) | 9 (17.6%) | <.001 |
| Impaired | 12 (41.4%) | 42 (82.4%) | |
| BT, median (95%CI) | 1.47 (0.18‐3.68) | 1.2 (0.13‐1.97) | .051 |
| TT, median (95%CI) | 7.32 (1‐12.87) | 4.73 (0.52‐10.92) | .026 |
| PRL, median (95%CI) | 12.6 (5.13‐38.9) | 11.4 (4.3‐40.9) | .993 |
| LH, median (95%CI) | 6.25 (1.44‐12.3) | 6.3 (1.42‐16.64) | .580 |
| FSH, median (95%CI) | 6.85 (2.82‐27.93) | 7.1 (2‐28.64) | .857 |
| SHBG, mean ± SD | 108.18 ± 48.2 | 93.43 ± 36.8 | .204 |
BT, bioavailable testosterone; ED, erectile dysfunction; FSH, follicle‐stimulating hormone; HVPG, hepatic venous pressure gradient; LH, luteinizing hormone; MELD, model for end‐stage liver disease score; PRL, prolactin; SHBG, sex hormone binding globulin; TT, total testosterone.
a
HVPG was available in 48 patients.
b
Status on oesophageal varices was available in 74 patients.
c
BB status was available in 75 patients, in 5 patients no information on BB intake was available owing to uncertain duration and frequency of BB intake.